|
|
||||||||
Department of Medicine, University of Sydney, Sydney 2006; and Centre for Respiratory Failure and Sleep Disorders, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia
Edwards, N., I. Wilcox, O. J. Polo, and C. E. Sullivan.
Hypercapnic blood pressure response is greater during the luteal phase of the menstrual cycle. J. Appl.
Physiol. 81(5): 2142-2146, 1996.
We investigated
the cardiovascular responses to acute hypercapnia during the menstrual
cycle. Eleven female subjects with regular menstrual cycles performed
hypercapnic rebreathing tests during the follicular and luteal phases
of their menstrual cycles. Ventilatory and cardiovascular variables
were recorded breath by breath. Serum progesterone and estradiol were
measured on each occasion. Serum progesterone was higher during the
luteal [50.4 ± 9.6 (SE) nmol/l] than during the
follicular phase (2.1 ± 0.7 nmol/l;
P < 0.001), but serum estradiol did
not differ (follicular phase, 324 ± 101 pmol/l; luteal phase, 162 ± 71 pmol/l; P = 0.61). The
systolic blood pressure responses during hypercapnia were 2.0 ± 0.3 and 4.0 ± 0.5 mmHg/Torr (1 Torr = 1 mmHg rise in
end-tidal PCO2) during the follicular
and luteal phases, respectively, of the menstrual cycle
(P < 0.01). The diastolic blood
pressure responses were 1.1 ± 0.2 and 2.1 ± 0.3 mmHg/Torr
during the follicular and luteal phases, respectively
(P < 0.002). Heart rate responses did not differ during the luteal (1.7 ± 0.3 beats · min
1 · Torr
1)
and follicular phases (1.4 ± 0.3 beats · min
1 · Torr
1;
P = 0.59). These data demonstrate a
greater pressor response during the luteal phase of the menstrual cycle
that may be related to higher serum progesterone concentrations.
follicular phase; progesterone; hypercapnic ventilatory
response
RESTING VENTILATION (23) and ventilatory responses to
hypercapnia (13) vary throughout the normal menstrual cycle in response to varying levels of serum progesterone, with an increase in both during the luteal phase. In addition, resting oxygen consumption has
been shown to be significantly greater during the luteal phase of the
menstrual cycle (1).
Blood pressure is known to be more reactive to physical
pressor-inducing stimuli such as the hand-grip test and the
cold-pressor test during the luteal phase of the menstrual cycle (19).
The pressor response to cocaine is enhanced in ewes after
administration of concentrations of progesterone similar to those found
during pregnancy (9). The reasons for the increased pressor response are unclear; however, there are a number of studies that link high
serum progesterone concentrations and increased sympathetically mediated responses (8, 9, 20).
In men, acute hypercapnia leads to a pressor response in the systemic
circulation (14, 15, 17), which is at least partially mediated via an
increased sympathetic tone (17), but this response has not been
reported in female subjects. The purpose of this study was to
investigate the pressor effect of acute hyperoxic hypercapnia during
the normal menstrual cycle.
Subjects. Eleven healthy Caucasian
women, aged 25 ± 1 (SE) yr (range 22-36 yr), all with normal
menstrual cycles, were included in the study. None of the subjects had
clinical evidence of a sleep disorder. All subjects had normal
spirometry; none was taking any regular medication, and none was
overweight (body mass index < 26 kg/m2).
Protocol. The subjects were studied on
at least two occasions, once during the follicular phase
(days 2-14) and at least once during the luteal phase of the cycle (days
15-27). The average day (absolute) on which the
women were studied during the follicular phase was day
8 of the menstrual cycle, and the average day on which
the study was performed during the luteal phase was
day 23. The average cycle length for
the group was 30 days. The phase of the cycle in which the first study
was performed was chosen arbitrarily; in seven subjects, the first
study was in the follicular phase and in four the luteal phase
(P = not significant). All tests were
performed at the same time of day. Venous blood was drawn on each
occasion before ventilatory-response testing for analysis of serum
estradiol and progesterone (CLIA-chemiluminescent immunoassay on
immulite). The intra- and interassay coefficients of
variation for estradiol were 15 and 16%, respectively, and for
progesterone 13 and 13%, respectively. Two subjects had anovulatory cycles (indicated by an absence of an increase in progesterone), and
their tests were repeated during the luteal phase of their next
menstrual cycle.
The effect of acute hyperoxic hypercapnia on arterial blood pressure
and ventilation was measured with a modification of the Read (11)
rebreathing method while the subjects were sitting awake and relaxed
with background music playing. Caffeine was withheld for at least 4 h,
and consumption of food was restricted for 2 h before each test.
The apparatus used for the studies consisted of a completely closed
6-liter biased-flow circuit comprising a 4-liter flow-through bag,
variable-bypass soda lime absorber, and fixed-speed blower. The
subjects were connected to the circuit, which was filled with 100%
O2, via a mouthpiece with the nose
occluded. Hypercapnia was induced by the addition of a bolus of
CO2, and the subjects were asked
to take three deep breaths to equilibrate the contents of the bag with
the lungs. If a plateau in inspired and expired CO2 was reached within six breaths
[indicating that the mixed venous, and thus brain,
PCO2 was near the expired
PCO2 (12)], the soda lime
absorber was disconnected and the subject was allowed to rebreathe her
own expired CO2. In the first test on each subject, rebreathing was sustained for 4 min or until the
subject could no longer tolerate further increases in end-tidal PCO2
(PETCO2). On subsequent
tests, subjects rebreathed until their maximum
PETCO2 matched that obtained on the first test. Airflow was measured with a pneumotachograph and
differential pressure transducer (DP45-14, Validyne, Northbridge, CA).
Tidal volume was calculated by digitally integrating the airflow
signal, and minute ventilation ( A 5-min control period was recorded during quiet breathing to provide a
baseline measurement of systemic blood pressure, heart rate,
PETCO2, and
Of 11 subjects, 9 had 1 pair of studies with 1 data set obtained in the
follicular phase and another in the luteal phase. The remaining two
subjects had anovulatory cycles (their serum progesterone concentration
in the luteal phase being <2 nmol/l), and these subjects were
restudied in the luteal phase of their next menstrual cycle.
All values are expressed as means ± SE for the group. Within-group
comparisons between the follicular and luteal phases were made with a
paired Student's t-test. A two-tailed
P value < 0.05 was considered
significant. P values > 0.1 are
reported as not significant.
Serum hormone concentrations. Serum
estradiol concentration (Table 1) was not
significantly different during the luteal and follicular phases.
Estradiol concentration ranged from 45 to 1,089 pmol/l in the
follicular phase and from 78 to 885 pmol/l in the luteal phase. Serum
progesterone concentration (Table 1) was found to be greater during the
luteal phase of the cycle, with the range in the follicular phase being
0.7-2.7 nmol/l and during the luteal phase 8.6-108 nmol/l.
Table 1.
Mean baseline ventilatory and cardiovascular recordings
I) was
calculated.
PETCO2 was measured
at the mouth with a capnometer (HP-47210A, Hewlett-Packard, Waltham,
MA). Arterial oxyhemoglobin saturation
(SaO2) and heart rate were measured
transcutaneously from the ear lobe with a pulse oximeter (Biox 3700E,
Ohmeda, Englewood, CO). Arterial blood pressure was measured
noninvasively with a self-calibrating finger photoplethysmograph (Finapres, Ohmeda, Englewood, CO).
PETCO2,
SaO2, blood pressure (systolic,
diastolic, and mean arterial), heart rate, and
I were analyzed breath by breath with
customized software (Laboratory Software, Leonay, Australia). The
ventilatory and blood pressure responses to hypercapnia were calculated
from the slope of the regression line plotted against
PETCO2 and expressed as the
change in
I (in l/min) and blood
pressure [systolic, diastolic, and mean arterial; in mmHg/Torr (1 Torr = 1 mmHg rise in
PETCO2)].
I. During the control period, all expired CO2 was absorbed by the
soda lime and SaO2 was maintained by
computer-controlled addition of O2
to the rebreathing circuit. Values obtained during the control period
for all subjects are expressed as means of the 5-min recordings.
Follicular Phase (Days 2-14)
Luteal
Phase (Days 15-28)
P Value
Progesterone, nmol/l
2.1 ± 0.7
50.4 ± 9.6
<0.001
Estradiol, pmol/l
324 ± 101
416 ± 71
NS
I, l/min 6.8 ± 0.3
7.2 ± 0.4
NS
PETCO2, Torr
40.7 ± 2.9
36.6 ± 0.9
0.09
SBP, mmHg
125 ± 1.6
123 ± 3.3
NS
DBP,
mmHg
73 ± 4.0
66 ± 3.6
0.09
MAP, mmHg
92 ± 3.3
85 ± 2.9
0.07
HR, beats/min
73 ± 3.1
75 ± 3.8
NS
Values are means ± SE from baseline recordings; n = 11 subjects.
I, minute ventilation;
PETCO2, end-tidal
PCO2; SBP, DBP, and MAP, systolic, diastolic,
and mean arterial blood pressure, respectively; HR, heart rate. Venous
blood for mean progesterone and estradiol concentration was drawn
before onset of baseline recording. P values were calculated
with paired 2-tailed t-tests. NS, not significant. P
values are >0.1.
Baseline recordings. During baseline recordings (Table 1), there was no significant difference in ventilatory and cardiovascular variables between the follicular and luteal phases. However, there was a trend toward PETCO2 being lower during the luteal phase of the menstrual cycle, but this did not reach the stipulated level of significance. Similarly, diastolic and mean arterial blood pressures tended toward being lower during the follicular phase of the menstrual cycle; however, these also did not reach significance.
Ventilatory responses. As previously
reported, the ventilatory responses during the luteal phase of the
menstrual cycle were significantly higher than during the follicular
phase (Fig. 1). The mean ventilatory
responses for the group during the follicular and luteal phases of the
menstrual cycle were 2.43 ± 0.28 l · min
1 · Torr
1
(range 0.6-4.6
l · min
1 · Torr
1)
and 3.81 ± 0.49 l · min
1 · Torr
1
(range 1.3-6.2
l · min
1 · Torr
1),
respectively (Table 2).
1 · Torr
1
(1 Torr = 1 mmHg rise in end-tidal
PCO2), and the systolic and diastolic
blood pressure responses were 2.7 and 1.8 mmHg/Torr, respectively.
Baseline end-tidal PCO2, minute
ventilation, and BP were 39 Torr, 7.8 l/min, and 120/60 mmHg,
respectively. B: recording during
luteal phase of menstrual cycle when serum estradiol concentration was
514 pmol/l and serum progesterone concentration was 48.3 nmol/l.
Ventilatory response was 5.0 l · min
1 · Torr
1,
and the systolic and diastolic blood pressure responses were 5.9 and
2.9 mmHg/Torr, respectively. Baseline end-tidal
PCO2, minute ventilation, and BP were
36 Torr, 8.1 l/min, and 119/74 mmHg, respectively. Follicular phase of
menstrual cycle was 1st study to be conducted in this patient, and
level of CO2 reached was
determined by length of time taken for the test (4 min, as stipulated
in METHODS). During luteal phase of
test, study was continued until end-tidal
PCO2 reached that of the 1st study.
Time taken for each test differed because of the markedly higher
ventilatory response in luteal phase causing an increased production of
CO2.
|
||||||||||||||||||||||||||||
Blood pressure responses. There was a
high variation in the systolic blood pressure response among the
subjects; however, the slope for each subject was always higher during
the luteal phase of their ovulatory cycles than during the follicular
phase. The range of systolic blood pressure responses during the
follicular phase was 0.2-4.2 mmHg/Torr and during the luteal phase
was 1.2-7.6 mmHg/Torr (Fig.
2). The range of diastolic
blood pressure responses during the follicular phase was 0.1-2.9
mmHg/Torr and during the luteal phase was 0.7-3.1 mmHg/Torr (Fig.
2). The average mean arterial blood pressure responses during the
follicular and luteal phases of the menstrual cycle were 1.35 and 2.71 mmHg/Torr, respectively (P < 0.005).
The systolic blood pressures during the follicular and luteal phases of the menstrual cycle at the onset of hypercapnia were 132 and 126 mmHg, respectively (P = 0.39) and at the conclusion of hypercapnia were 140 and 162 mmHg, respectively (P < 0.02). The diastolic blood pressures for the follicular and luteal phases at the onset of hypercapnia were 74 and 74 mmHg, respectively (P = 0.95). At the conclusion of hypercapnia, the diastolic blood pressures for the follicular and luteal phases of the menstrual cycle were 76 and 96 mmHg, respectively (P < 0.01).
In the two subjects who had anovulatory cycles, there was little difference in the blood pressure responses during the two different phases of the menstrual cycle. The systolic blood pressure responses for these two subjects were 2.17 and 2.07 mmHg/Torr during the follicular phase and 2.18 and 1.25 mmHg/Torr during the luteal phase.
Heart rate responses. The mean heart
rate responses were similar during the follicular (1.4 ± 0.6 beats · min
1 · Torr
1)
and luteal phases (1.7 ± 0.3 beats · min
1 · Torr
1;
P = 0.57) of the menstrual cycle. The
range of heart rate responses in the follicular and luteal phases were
0.0-3.3 and 0.2-4.6
beats · min
1 · Torr
1,
respectively.
This study has demonstrated that the systemic arterial blood pressure response to acute hyperoxic hypercapnia is greater during the luteal phase of the menstrual cycle. Furthermore, we have shown that the heart rate response to hypercapnia is unchanged between the two phases of the menstrual cycle.
The phase of the menstrual cycle during which the first study was conducted was chosen arbitrarily and was equally liable to have been performed in either of the phases of the cycle, making it unlikely that an order effect influenced our findings.
Previous studies have shown that anovulatory menstrual cycles are common in normal premenopausal women who report regular menstrual cycles (22). For this reason, it was important, even in subjects reporting regular menstrual cycles, to confirm ovulation by the measurement of serum concentrations of progesterone and estradiol. The importance of this was demonstrated during the protocol when two of the women studied had anovulatory cycles. Notably, these two subjects had no change in their pressor response between the two phases.
The Finapres device that was used for recording arterial blood pressure during these studies is a commonly used noninvasive method of accurately recording arterial blood pressure. The device has been correlated with the intra-arterial ipsilateral blood pressure recordings in both the steady-state and dynamic blood pressure systems. Even for rapidly dynamic blood pressure recordings (in a range of 86-266 mmHg), the measurements obtained by the device correlate closely with intra-arterial recordings. The correlation coefficients for systolic, diastolic, and mean arterial blood pressures in this study were 0.97, 0.93, and 0.97, respectively (4).
Progesterone is a respiratory stimulant (26) and increases the
ventilatory drive to hypercapnia (23), and thus basal
I is significantly higher (18) and
PETCO2 significantly lower
(13) in the luteal phase of the menstrual cycle. In the present study,
basal
I did not change significantly over
the course of the menstrual cycle; however, we did demonstrate a trend toward a lower PETCO2. The
principal goal of this study was to examine ventilatory and systemic
arterial blood pressure responses to hypercapnia and not specifically
to reexamine changes in baseline
I.
Interestingly, there was also a trend toward lower basal systolic and
diastolic blood pressure measurements during the luteal phase of the
menstrual cycle. Although the aim of this study was to measure pressor
responses to hypercapnia and not basal changes in blood pressure, we
demonstrated a trend toward lower basal diastolic
(P = 0.09) and mean arterial blood pressures (P = 0.07) during the luteal
phase of the menstrual cycle, findings in agreement with Dunne et al.
(2).
We propose that a major factor influencing the increased pressor response to hypercapnia during the luteal phase of the menstrual cycle is the upregulation of catecholamine receptors within the cardiovascular system. There are a number of studies that suggest that catecholamine receptors are upregulated in the presence of higher levels of progesterone. The toxic response to cocaine (a sympathomimetic) is much greater after administration of progesterone in doses similar to those occurring during pregnancy. Re et al. (10) have suggested that parenteral administration of progesterone results in increased sympathetic tone in cardiac muscle. Both Mehta and Chakrabarty (8) and Tollan et al. (20) showed evidence of increased sympathetic activity (increased blood pressure and increased sweating) during the luteal phase of the menstrual cycle. However, Tollan et al. (20) also showed that even though blood pressure is increased in the luteal phase of the cycle, net serum catecholamine concentrations are reduced. Trzebski and Kubin (21) have suggested that the pressor response to hypercapnia in male subjects is mediated via central control mechanisms increasing peripheral sympathetic tone. Thus it is probable that although acute hyperoxic hypercapnia leads to a similar increase in sympathetic output during the two different phases of the cycle, the postulated upregulation of sympathetic receptors by progesterone during the luteal phase results in a greater response.
Other potential mechanisms of the increased pressor response to hypercapnia must be considered. Progesterone increases intravascular volume, and this could lead to an increased mean circulatory filling pressure and hence an increased cardiac output (mediated via a greater stroke volume). Mean circulatory filling pressure increases reflexly under hypercapnic conditions due to stimulation of aortic arch chemoreceptors (14). Under these circumstances, the pressor effect of hypercapnia would be increased in the presence of a greater intravascular volume. It is unlikely that alterations in parasympathetic tone contributed to the increased pressor response to hypercapnia, because parasympathetic function is believed to be unaltered by the phase of the menstrual cycle (8).
It is clear from the results of this study that the menstrual cycle is an important factor in determining the blood pressure response to hypercapnia. There are a number of implications of these findings when considered in conjunction with other studies reporting greater systemic blood pressure responses to a variety of pressor-inducing stimuli during the luteal phase of the menstrual cycle. Importantly, these results suggest an increased risk of cardiovascular accidents during pressor-inducing activities in the luteal phase of the menstrual cycle. However, obstructive sleep apnea (OSA) in premenopausal women may be another very important public health issue when considered in the context of the results reported in the present study. Blood pressure increases acutely in response to apnea in men with OSA (16). One mechanism that may be involved in the acute pressor response after apnea is the transient increase in PETCO2. Although OSA is classically reported to occur predominantly in men and postmenopausal women (24), there is increasing evidence that OSA also occurs commonly in premenopausal women, with one epidemiological study suggesting that 4.9% of women aged 30-49 yr have significant OSA (25). According to the data presented here, premenopausal women may have an enhanced pressor response to apnea during the luteal phase of each menstrual cycle. Male sleep apneics often present with daytime hypertension (3), and OSA is suggested to be a major risk factor for the development of hypertension (3, 6, 7, 17). The risk of stroke and acute myocardial infarct are also increased in men with OSA (5). No similar data on cardiovascular morbidity and mortality in OSA exist for premenopausal women. However, if the pressor response to obstructive sleep apnea is enhanced in premenopausal women during the luteal phase of the menstrual cycle, then the occurence of OSA may pose an even greater risk for the development of hypertension and vascular disease in these women.
In conclusion, this study has demonstrated an increased pressor response to acute hyperoxic hypercapnia during the luteal phase of the menstrual cycle. This effect is associated with higher serum progesterone concentrations, which may either modify the sympathetic response to hypercapnia by upregulation of sympathetic adrenoceptors at the level of the heart and blood vessels or increase intravascular volume. The results suggest a profound influence of the menstrual cycle on cardiovascular control in premenopausal women with OSA.
The authors gratefully acknowledge the assistance of Dr. Thomas Wessendorf and Dr. Heinrich Becker for taking venous blood samples, the Royal Prince Alfred Hospital (Camperdown, Australia) Endocrinology Laboratory for analyzing serum hormone concentrations, Monique Aarts for assistance in performing tests, and Gunnar Ungar for technical expertise in keeping the ventilatory-response circuit working and for providing technical information on the components involved in the circuit.
Address for reprint requests: C. E. Sullivan, Dept. of Medicine, Blackburn Bldg. (D06), Univ. of Sydney, Sydney, New South Wales 2006, Australia.
Received 23 October 1995; accepted in final form 10 April 1996.
| 1. | Das, T. K., and H. Jana. Basal oxygen consumption during different phases of menstrual cycle. Indian J. Med. Res. 94: 16-19, 1991. |
| 2. | Dunne, F. P., D. G. Barry, J. B. Ferriss, G. Grealy, and D. Murphy. Changes in blood pressure during the normal menstrual cycle. Clin. Sci. Lond. 81: 515-518, 1991. |
| 3. | Fletcher, E. C., R. D. DeBehnke, M. S. Lovoi, and A. B. Gorin. Undiagnosed sleep apnea in patients with essential hypertension. Ann. Intern. Med. 103: 190-195, 1985. |
| 4. | Gabriel, A., L. E. Linblad, and C. Angleryd. Noninvasive versus invasive beat-to-beat monitoring of blood pressure. Clin. Physiol. Oxf. 12: 229-235, 1992. |
| 5. | Hedner, J. A., I. Wilcox, and C. E. Sullivan. Speculations on the interaction between vascular disease and obstructive sleep apnea. In: Sleep and Breathing, edited by N. A. Saunders, and C. E. Sullivan. New York: Dekker, 1994, vol. 71, p. 823-846. (Lung Biol. Health Dis. Ser.) |
| 6. | Hla, K. M., T. B. Young, T. Bidwell, M. Palta, J. B. Skatrud, and J. Dempsey. Sleep apnea and hypertension. A population-based study. Ann. Intern. Med. 120: 382-388, 1994. |
| 7. | Lund-Johansen, P., and W. B. White. Central hemodynamics and 24-hour blood pressure in obstructive sleep apnea syndrome: effects of corrective surgery. Am. J. Med. 88: 678-682, 1990. |
| 8. | Mehta, V., and A. S. Chakrabarty. Autonomic functions during different phases of menstrual cycle. Indian J. Physiol. Pharmacol. 37: 56-58, 1993. |
| 9. | Plessinger, M. A., and J. R. Woods, Jr. Progesterone increases cardiovascular toxicity to cocaine in nonpregnant ewes. Am. J. Obstet. Gynecol. 163: 1659-1664, 1990. |
| 10. | Re, M., A. Gemelli, M. Falcone, G. Leone, M. Pacelli, G. Galeotta, and G. Clemenzia. Cardiovascular effects induced by progesterone administration. Panminerva Med. 31: 28-29, 1989. |
| 11. | Read, D. J. C. A clinical method for assessing the ventilatory response to hypercapnia. Australas. Ann. Med. 16: 20-32, 1967. |
| 12. | Read, D. J. C., and J. Leigh. Blood-brain tissue PCO2 relationships and ventilation during rebreathing. J. Appl. Physiol. 23: 53-70, 1967. |
| 13. | Regensteiner, J. G., W. D. Woodard, J. V. Hagerman, J. V. Weil, C. K. Pickett, P. R. Bender, and L. G. Moore. Combined effects of female hormones and metabolic rate on ventilatory drives in women. J. Appl. Physiol. 66: 808-813, 1989. |
| 14. | Rothe, C. F., R. Maass-Moreno, and A. D. Flanagan. Effects of hypercapnia and hypoxia on the cardiovascular system: vascular capacitance and aortic arch chemoreceptors. Am. J. Physiol. 259 (Cell Physiol. 28): C932-C939, 1990. |
| 15. | Serebrovskaya, T. V. Comparison of respiratory and circulatory human responses to progressive hypoxia and hypercapnia. Respiration 59: 35-41, 1992. |
| 16. | Shepard, J. W., Jr. Gas exchange and hemodynamics during sleep. Med. Clin. North Am. 69: 1243-1264, 1985. |
| 17. | Shepard, J. W., Jr. Cardiopulmonary consequences of obstructive sleep apnea. Mayo Clin. Proc. 65: 1250-1259, 1990. |
| 18. | Takano, N. Resting pulmonary ventilation and dead space ventilation during the menstrual cycle. Jpn. J. Physiol. 32: 469-473, 1982. |
| 19. | Tersman, Z., A. Collins, and P. Eneroth. Cardiovascular responses to psychological and physiological stressors during the menstrual cycle. Psychosom. Med. 53: 185-197, 1991. |
| 20. | Tollan, A., P. Oian, S. E. Kjeldsen, I. Eide, and J. M. Maltau. Progesterone reduces sympathetic tone without changing blood pressure or fluid balance in men. Gynecol. Obstet. Invest. 36: 234-238, 1993. |
| 21. | Trzebski, A., and L. Kubin. Is the central inspiratory activity responsible for PCO2-dependent drive of the sympathetic discharge. J. Auton. Nerv. Syst. 3: 401-420, 1981. |
| 22. | Vuorento, T., A. Lahti, O. Hovatta, and I. Huhtaniemi. Daily measurements of salivary progesterone reveal a high rate of anovulation in healthy students. Scand. J. Clin. Lab. Invest. 49: 395-401, 1989. |
| 23. | White, D. P., N. J. Douglas, C. K. Pickett, J. V. Weil, and C. W. Zwillich. Sexual influence on the control of breathing. J. Appl. Physiol. 54: 874-879, 1983. |
| 24. | Wilhoit, S. C., and P. M. Suratt. Obstructive sleep apnea in premenopausal women. A comparison with men and with postmenopausal women. Chest 91: 654-658, 1987. |
| 25. | Young, T. B., J. Palta, J. Dempsey, J. Skatrud, S. Weber, and S. Badr. Occurence of sleep disordered breathing among middle-aged adults. N. Engl. J. Med. 328: 1230-1235, 1993. |
| 26. | Zwillich, C., M. Natalino, F. Sutton, and J. Weil. Effects of progesterone on chemosensitivity in normal man. J. Clin. Lab. Med. 92: 262-269, 1978. |
This article has been cited by other articles:
![]() |
F. Labombarda, A. Pianos, P. Liere, B. Eychenne, S. Gonzalez, A. Cambourg, A. F. De Nicola, M. Schumacher, and R. Guennoun Injury Elicited Increase in Spinal Cord Neurosteroid Content Analyzed by Gas Chromatography Mass Spectrometry Endocrinology, April 1, 2006; 147(4): 1847 - 1859. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yinon, L. Lowenstein, S. Suraya, R. Beloosesky, O. Zmora, A. Malhotra, and G. Pillar Pre-eclampsia is associated with sleep-disordered breathing and endothelial dysfunction Eur. Respir. J., February 1, 2006; 27(2): 328 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Henderson, M. A. Woo, P. M. Macey, K. E. Macey, R. C. Frysinger, J. R. Alger, F. Yan-Go, and R. M. Harper Neural responses during Valsalva maneuvers in obstructive sleep apnea syndrome J Appl Physiol, March 1, 2003; 94(3): 1063 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Brutsaert, H. Spielvogel, E. Caceres, M. Araoz, R. T. Chatterton, and V. J. Vitzthum Effect of menstrual cycle phase on exercise performance of high-altitude native women at 3600 m J. Exp. Biol., January 15, 2002; 205(2): 233 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Muza, P. B. Rock, C. S. Fulco, S. Zamudio, B. Braun, A. Cymerman, G. E. Butterfield, and L. G. Moore Women at altitude: ventilatory acclimatization at 4,300 m J Appl Physiol, October 1, 2001; 91(4): 1791 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Leon-Velarde, M. Rivera-Chira, R. Tapia, L. Huicho, and C. Monge-C Relationship of ovarian hormones to hypoxemia in women residents of 4,300 m Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R488 - R493. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saaresranta, P. Polo-Kantola, K. Irjala, H. Helenius, and O. Polo Respiratory Insufficiency in Postmenopausal Women: Sustained Improvement of Gas Exchange With Short-term Medroxyprogesterone Acetate Chest, June 1, 1999; 115(6): 1581 - 1587. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Beidleman, P. B. Rock, S. R. Muza, C. S. Fulco, V. A. Forte Jr., and A. Cymerman Exercise VE and physical performance at altitude are not affected by menstrual cycle phase J Appl Physiol, May 1, 1999; 86(5): 1519 - 1526. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |